Redsense Medical AB (publ) (XSAT:REDS)
3.390
+0.090 (2.73%)
At close: Mar 18, 2026
Redsense Medical AB Market Cap
Redsense Medical AB has a market cap or net worth of 54.27 million as of March 18, 2026. Its market cap has decreased by -55.76% in one year.
Market Cap
54.27M
Enterprise Value
46.91M
Revenue
26.80M
Ranking
n/a
PE Ratio
7.50
Stock Price
3.39
Market Cap Chart
Since June 17, 2015, Redsense Medical AB's market cap has increased from 29.11M to 54.27M, an increase of 86.42%. That is a compound annual growth rate of 5.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 54.27M | -20.48% |
| Dec 30, 2025 | 68.25M | -41.55% |
| Dec 30, 2024 | 116.76M | 9.42% |
| Dec 29, 2023 | 106.71M | -19.83% |
| Dec 30, 2022 | 133.11M | -61.46% |
| Dec 30, 2021 | 345.40M | -44.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smoltek Nanotech Holding AB | 96.91M |
| SolidX AB | 92.75M |
| QBNK Holding AB | 63.38M |
| BiBBInstruments AB | 55.61M |
| Sound Dimension AB | 52.99M |
| Touchtech AB | 46.78M |
| Genetic Analysis AS | 41.43M |
| Vidhance AB | 32.97M |